Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma.

Bergqvist, A S; Bergqvist, M; Brattstrom, D; Hesselius, P; Larsson, A; Brodin, O; Wagenius, G

Bergqvist, A S; Bergqvist, M; Brattstrom, D; Hesselius, P; Larsson, A; Brodin, O; Wagenius, G.

Affiliation

Bergqvist AS; Department of Oncology, Radiology and Clinical Immunology, Uppsala University Hospital, Sweden.

Anticancer Res ; 21(6A): 4141-5, 2001.

Article in En | MEDLINE | ID: mdl-11911308

Subject(s)

Autoantibodies/blood; Esophageal Neoplasms/immunology; Tumor Suppressor Protein p53/immunology; Adenocarcinoma/immunology; Biomarkers, Tumor/blood; Biomarkers, Tumor/immunology; Carcinoma, Adenosquamous/immunology; Carcinoma, Squamous Cell/immunology; Female; Humans; Male; Prognosis; Prospective Studies; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Esophageal Neoplasms / Tumor Suppressor Protein p53 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Anticancer Res Year: 2001 Document type: Article Affiliation country: Sweden

Search on Google

Add to My VHL

XML

PubMed Links